Clinical Trial Update: Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether desvenlafaxine affects the pharmacokinetics of midazolam. The study, in participants with major depressive disorder, has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)
• Midazolam (Midazolam)

Snippet

Sponsor: Pfizer | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2011-08-02